<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10">Towards the end of the year 2019, a new variant of Coronaviruses, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged from East Asia. The SARS-CoV-2 causes respiratory infections of varying disease severity in humans, ranging from asymptomatic to severe cases [
 <xref ref-type="bibr" rid="CR5">5</xref>]. The virus is transmitted via respiratory droplets and aerosols from both symptomatic and asymptomatic individuals [
 <xref ref-type="bibr" rid="CR6">6</xref>â€“
 <xref ref-type="bibr" rid="CR10">10</xref>]. With international travel facilitating the rapid spread of the virus, many countries including those in Africa adopted syndromic screening at ports of entry as a measure to curb its spread, with evidence showing a delay to the onset of outbreaks by a week [
 <xref ref-type="bibr" rid="CR11">11</xref>]. However, syndromic screening has its own shortfalls given its inadequacies at detecting asymptomatic individuals [
 <xref ref-type="bibr" rid="CR12">12</xref>].
</p>
